X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene.
暂无分享,去创建一个
A. Poustka | T. Vulliamy | G. Lestringant | G. Stavrides | P. Mason | I. Dokal | N. Heiss | N. Varma | S. Greschner | G. Pai | S. Knight | Annemarie Poustka | Philip J. Mason
[1] A. Poustka,et al. Dyskeratosis Congenita Caused by a 3′ Deletion: Germline and Somatic Mosaicism in a Female Carrier , 1999 .
[2] A. Poustka,et al. Dyskeratosis congenita caused by a 3' deletion: germline and somatic mosaicism in a female carrier. , 1999, Blood.
[3] T. Vulliamy,et al. Dyskeratosis Congenita (DC) Registry: identification of new features of DC , 1998, British journal of haematology.
[4] A. Poustka,et al. 1.4 Mb candidate gene region for X linked dyskeratosis congenita defined by combined haplotype and X chromosome inactivation analysis. , 1998, Journal of medical genetics.
[5] C. Cadwell,et al. The Nop60B gene of Drosophila encodes an essential nucleolar protein that functions in yeast , 1998, Molecular and General Genetics MGG.
[6] J. Goldman,et al. Chromosomal breakage analysis in dyskeratosis congenita peripheral blood lymphocytes , 1998, British journal of haematology.
[7] S. Klauck,et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions , 1998, Nature Genetics.
[8] L. Luzzatto,et al. Dyskeratosis and ribosomal rebellion , 1998, Nature Genetics.
[9] D. Tollervey,et al. The box H + ACA snoRNAs carry Cbf5p, the putative rRNA pseudouridine synthase. , 1998, Genes & development.
[10] B. Zonneveld,et al. The lysine‐rich C‐terminal repeats of the centromere‐binding factor 5 (Cbf5) of Kluyveromyces lactis are not essential for function , 1998, Yeast.
[11] R. Planta,et al. The yeast gene YNL292w encodes a pseudouridine synthase (Pus4) catalyzing the formation of psi55 in both mitochondrial and cytoplasmic tRNAs. , 1997, Nucleic acids research.
[12] C. Cadwell,et al. The yeast nucleolar protein Cbf5p is involved in rRNA biosynthesis and interacts genetically with the RNA polymerase I transcription factor RRN3 , 1997, Molecular and cellular biology.
[13] T. Vulliamy,et al. Skewed X-inactivation in carriers of X-linked dyskeratosis congenita. , 1997, Blood.
[14] A. Ferraris,et al. Nonrandom X-chromosome inactivation in hemopoietic cells from carriers of dyskeratosis congenita. , 1997, American journal of human genetics.
[15] M. Alikaşifoğlu,et al. Dyskeratosis congenita with an unusual chromosomal abnormality. , 1997, British journal of haematology.
[16] K. Devriendt,et al. Skewed X-chromosome inactivation in female carriers of dyskeratosis congenita. , 1997, American journal of human genetics.
[17] S. Kenwrick,et al. Linkage Analysis in 16 Families with Incontinentia pigmenti , 1997, European journal of human genetics : EJHG.
[18] E V Koonin,et al. Pseudouridine synthases: four families of enzymes containing a putative uridine-binding motif also conserved in dUTPases and dCTP deaminases. , 1996, Nucleic acids research.
[19] P. Patel,et al. Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion , 1996, Science.
[20] J. Gécz,et al. Splicing mutation in the ATR-X gene can lead to a dysmorphic mental retardation phenotype without alpha-thalassemia. , 1996, American Journal of Human Genetics.
[21] I. Dokal. Dyskeratosis congenita: an inherited bone marrow failure syndrome , 1996, British journal of haematology.
[22] W. Miller,et al. T-->A transversion 11 bp from a splice acceptor site in the human gene for steroidogenic acute regulatory protein causes congenital lipoid adrenal hyperplasia. , 1995, Human molecular genetics.
[23] J. Ofengand,et al. Purification, cloning, and properties of the tRNA psi 55 synthase from Escherichia coli. , 1995, RNA.
[24] G. Blobel,et al. NAP57, a mammalian nucleolar protein with a putative homolog in yeast and bacteria [published erratum appears in J Cell Biol 1998 Jan 26;140(2):447] , 1994, The Journal of cell biology.
[25] L. Luzzatto,et al. Dyskeratosis congenita is a chromosomal instability disorder. , 1994, Leukemia & lymphoma.
[26] A. Smahi,et al. The gene for the familial form of incontinentia pigmenti (IP2) maps to the distal part of Xq28. , 1994, Human molecular genetics.
[27] K. Middleton,et al. An essential yeast protein, CBF5p, binds in vitro to centromeres and microtubules , 1993, Molecular and cellular biology.
[28] B. Alter,et al. Dyskeratosis Congenita: Clinical and Genetic Heterogeneity Report of a New Case and Review of the Literature , 1992, The American journal of pediatric hematology/oncology.
[29] G. Blobel,et al. Nopp 140 shuttles on tracks between nucleolus and cytoplasm , 1992, Cell.
[30] D R Bentley,et al. A variable number of tandem repeats locus within the human complement C2 gene is associated with a retroposon derived from a human endogenous retrovirus , 1992, The Journal of experimental medicine.
[31] W. Krone,et al. Cytogenetic studies of skin fibroblast cultures from a karyotypically normal female with dyskeratosis congenita , 1992, Clinical genetics.
[32] R. Heilig,et al. Rapid PCR analysis of the St14 (DXS52) VNTR. , 1991, Nucleic acids research.
[33] G. Loudianos,et al. Molecular characterization of beta-thalassemia intermedia in patients of Italian descent and identification of three novel beta-thalassemia mutations. , 1991, Blood.
[34] G. Pai,et al. Bleomycin hypersensitivity in dyskeratosis congenita fibroblasts, lymphocytes, and transformed lymphoblasts. , 1989, Cytogenetics and cell genetics.
[35] D. Labie,et al. A novel beta thalassemia gene with a single base mutation in the conserved polypyrimidine sequence at the 3' end of IVS 2. , 1988, Nucleic acids research.
[36] M. Ono,et al. A novel human nonviral retroposon derived from an endogenous retrovirus. , 1987, Nucleic acids research.
[37] J. Connor,et al. Assignment of the gene for dyskeratosis congenita to Xq28 , 1986, Human Genetics.
[38] Stephen M. Mount,et al. A catalogue of splice junction sequences. , 1982, Nucleic acids research.